Summary
Avantor: The Q4 Dip Could Have Priced In All The Negatives
Avantor is a turnaround play in life sciences distribution and manufacturing, trading at a historically low valuation after a 50% stock decline. New management is executing a Revival program targeting $400M in cost savings, debt reduction, and organizational restructuring to restore growth and margins. 2026 guidance remains cautious, with revenue and adjusted EPS expected to decline, but stabilization and growth are anticipated in 2027.
New Strong Sell Stocks for February 17th
AVTR, CMCO and KHC have been added to the Zacks Rank #5 (Strong Sell) List on February 17th, 2026.
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
Avantor stock sinks 13% as Q4 earnings beat estimates, but revenues slip, margins contract and 2026 outlook signals more pressure ahead.
Avantor Inc. (AVTR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Avantor Inc. ever had a stock split?
Avantor Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Emmanuel Ligner CEO | NYSE Exchange | 05352A100 CUSIP |
| US Country | 13,500 Employees | - Last Dividend | - Last Split | 17 May 2019 IPO Date |
Overview
Avantor, Inc. is a global provider known for offering critical products and services across various industries, including biopharma, healthcare, education and government, as well as advanced technologies and applied material sectors. With a rich history dating back to 1904, Avantor operates in the Americas, Europe, Asia, the Middle East, and Africa. Positioned as an essential partner for its clients, Avantor's support is pivotal in the fields of scientific research, healthcare, and manufacturing, among others. The company maintains its headquarters in Radnor, Pennsylvania, underlining its long-standing commitment to excellence and innovation in serving its customers' needs.
Products and Services
Materials and Consumables: These include high-purity chemicals and reagents, lab products, and supplies aimed at various research and development applications. Avantor also specializes in formulated silicone materials, customized excipients (substances added to drugs to support the active ingredients), and single-use assemblies tailored to specific projects. Further offerings encompass process chromatography resins and columns, analytical sample preparation kits, education and microbiology products, clinical trial kits, and peristaltic pumps along with fluid handling tips. These products are essential for customers involved in scientific research and manufacturing processes.
Equipment and Instrumentation: Avantor provides a range of vital equipment such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and supplies for critical environments. This equipment is crucial for maintaining precise conditions in laboratories and manufacturing settings, ensuring the integrity and accuracy of experiments and products.
Services and Specialty Procurements: The company's service offerings include onsite lab and production support, clinical services, equipment services, procurement and sourcing solutions, and biopharmaceutical material scale-up and development services. Avantor's expertise extends to providing scientific research support services, including DNA extraction, bioreactor servicing, clinical and biorepository services, and compound management. These services enable clients to optimize their operations, manage costs, and accelerate the development of new products and therapies.
